ARTICLE | Clinical News
HyperAcute Renal: Phase I started
January 6, 2014 8:00 AM UTC
On Dec. 19, 2013, NewLink began a dose-escalation Phase I trial to evaluate intradermal HyperAcute Renal immunotherapy in up to 20 patients with recurrent or refractory, metastatic clear cell renal ca...